Overview
Calculate indicative Mesoblast (MSB) price on ASX equivalent price from MESO (NASDAQ) and AUD/USD exchange rate data.
Calculates indicative MSB (ASX) equivalent price from MESO (NASDAQ) and AUD/USD market data. Mesoblast is an Australian regenerative medicine and biopharmaceutical company focused on developing allogeneic (off-the-shelf) cellular medicines. Their therapies, derived from mesenchymal stem cells (MSCs) extracted from adult bone marrow, are designed to treat severe and life-threatening inflammatory conditions, cardiovascular diseases, and orthopedic disorders.
Details
- Version3.0.0
- UpdatedJune 21, 2026
- Offered byrvpnrp
- Size485KiB
- LanguagesEnglish
- Developer
Email
rvpnrp@gmail.com - Non-traderThis developer has not identified itself as a trader. For consumers in the European Union, please note that consumer rights do not apply to contracts between you and this developer.
Privacy
MESO & MSB Tracker has disclosed the following information regarding the collection and usage of your data. More detailed information can be found in the developer's privacy policy.
MESO & MSB Tracker handles the following:
This developer declares that your data is
- Not being sold to third parties, outside of the approved use cases
- Not being used or transferred for purposes that are unrelated to the item's core functionality
- Not being used or transferred to determine creditworthiness or for lending purposes
